Uncategorized

Lilly just bought renowned regulator Peter Marks a pipeline to play with

Published

on

FDA veteran Peter Marks will now shape the future of Eli Lilly’s vaccines work after the buys of Curevo, LimmaTech Biologics and Vaccine Company for up to $3.8 billion total.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version